Previous research demonstrated that deubiquitination enzyme genes play a role in developing drug resistance in malignant tumors and that interference with PSMD14 or PSMD14 inhibitors can reverse drug resistance in malignant tumors. The gene discussed is PSMD14; the disease is cancer.